Joseph Tintelnot
Has participated in:
-
Ontogenetische und funktionelle Analyse Arc-, Arg3.1-exprimierender dendritischer Zellen und Langerhans-Zellen
-
Efficacy and quality of life for FOLFOX/bevacizumab +/− irinotecan in first-line metastatic colorectal cancer—final results of the AIO CHARTA trial
-
Combining Poly-(ARD-Ribose) Polymerase and Programmed Cell Death Protein 1 Inhibition in a Patient with Esophagogastric Adenocarcinoma
-
Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer